Director's Consumer Liaison Group
The Committee shall advise and make recommendations
to the Director, NCI, from the perspective and viewpoint of cancer
consumer advocates on a wide variety of issues, programs and
research priorities. The Committee shall serve as a channel for
consumer advocates to voice their views and concerns.
FDA Advisory Committee News
and Information fdaadvisorycommittee.com
IRB - Human Subject Protections
Participating in IRBs will let you participate
in trial design in order to protect trial subjects and maximize
participation as well.
NCI program: CARRA
As a CARRA member, you may be selected to
participate in a CARRA activity. Your participation is important
because you bring the unique perspective of someone
affected by cancer and represent others also affected by the disease.
Patient Consultant to the FDA
The Food and Drug Administration (FDA) is
initiating a new program, the Cancer Drug Development
Program to incorporate the perspective of patient
advocates into the drug development process. This program will
provide cancer patient advocates an opportunity to participate in
the FDA drug review regulatory process.
Patient Representative in Advisory Committees
The Food and Drug Administration seeks input
from consumers on medical and scientific issues. A key method of
ensuring that FDA gets consumers' points of view is by including
consumer representatives on Agency advisory committees.